Electronic medical record systems are associated with appropriate placement of HIV patients on antiretroviral therapy in rural health facilities in Kenya: a retrospective pre-post study.

Tom Oluoch, Abraham Katana, Victor Ssempijja, Daniel Kwaro, Patrick Langat, Davies Kimanga, Nicky Okeyo, Ameen Abu-Hanna, Nicolette de Keizer
Author Information
  1. Tom Oluoch: Division of Global HIV/AIDS, US Centers for Disease Control and Prevention, Nairobi, Kenya.
  2. Abraham Katana: Division of Global HIV/AIDS, US Centers for Disease Control and Prevention, Nairobi, Kenya.
  3. Victor Ssempijja: Division of Global HIV/AIDS, US Centers for Disease Control and Prevention, Nairobi, Kenya.
  4. Daniel Kwaro: Kenya Medical Research Institute, CDC Collaborative Program, Kisumu, Kenya.
  5. Patrick Langat: Kenya Medical Research Institute, CDC Collaborative Program, Kisumu, Kenya.
  6. Davies Kimanga: Ministry of Health, National AIDS and STI Control Program, Nairobi, Kenya.
  7. Nicky Okeyo: Kenya Medical Research Institute, CDC Collaborative Program, Kisumu, Kenya.
  8. Ameen Abu-Hanna: Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  9. Nicolette de Keizer: Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Abstract

BACKGROUND AND OBJECTIVE: There is little evidence that electronic medical record (EMR) use is associated with better compliance with clinical guidelines on initiation of antiretroviral therapy (ART) among ART-eligible HIV patients. We assessed the effect of transitioning from paper-based to an EMR-based system on appropriate placement on ART among eligible patients.
METHODS: We conducted a retrospective, pre-post EMR study among patients enrolled in HIV care and eligible for ART at 17 rural Kenyan clinics and compared the: (1) proportion of patients eligible for ART based on CD4 count or WHO staging who initiate therapy; (2) time from eligibility for ART to ART initiation; (3) time from ART initiation to first CD4 test.
RESULTS: 7298 patients were eligible for ART; 54.8% (n=3998) were enrolled in HIV care using a paper-based system while 45.2% (n=3300) were enrolled after the implementation of the EMR. EMR was independently associated with a 22% increase in the odds of initiating ART among eligible patients (adjusted OR (aOR) 1.22, 95% CI 1.12 to 1.33). The proportion of ART-eligible patients not receiving ART was 20.3% and 15.1% for paper and EMR, respectively (χ(2)=33.5, p<0.01). Median time from ART eligibility to ART initiation was 29.1 days (IQR: 14.1-62.1) for paper compared to 27 days (IQR: 12.9-50.1) for EMR.
CONCLUSIONS: EMRs can improve quality of HIV care through appropriate placement of ART-eligible patients on treatment in resource limited settings. However, other non-EMR factors influence timely initiation of ART.

Keywords

References

PLoS One. 2012;7(12):e51631 [PMID: 23284728]
AMIA Annu Symp Proc. 2010 Nov 13;2010:167-71 [PMID: 21346962]
J Am Med Inform Assoc. 2011 Mar-Apr;18(2):150-5 [PMID: 21252053]
Inform Prim Care. 2008;16(2):139-45 [PMID: 18713530]
Curr HIV Res. 2011 Sep;9(6):470-2 [PMID: 21999780]
N Engl J Med. 2011 Sep 1;365(9):825-33 [PMID: 21879900]
Appl Clin Inform. 2012 Aug 01;3(3):309-17 [PMID: 23646078]
J Am Med Inform Assoc. 2011 Nov-Dec;18(6):868-74 [PMID: 21565857]
Curr Opin Infect Dis. 2012 Oct;25(5):477-83 [PMID: 22744319]
AIDS Res Hum Retroviruses. 2009 Feb;25(2):127-33 [PMID: 19239353]
J Clin Pathol. 2006 May;59(5):533-6 [PMID: 16461564]
Stud Health Technol Inform. 2010;160(Pt 1):337-41 [PMID: 20841704]
AMIA Annu Symp Proc. 2010 Nov 13;2010:232-6 [PMID: 21346975]
J Womens Health (Larchmt). 2013 Feb;22(2):113-20 [PMID: 23350862]
AIDS. 2012 Jul 31;26(12):1545-54 [PMID: 22441254]
AIDS Care. 2011 Jul;23(7):814-21 [PMID: 21400312]
AIDS Behav. 2012 Feb;16(2):368-74 [PMID: 21739285]

Grants

  1. U01 GH000048/CGH CDC HHS
  2. GH000048-04/PEPFAR

MeSH Term

Adult
Anti-Retroviral Agents
CD4 Lymphocyte Count
Electronic Health Records
Female
HIV Infections
Humans
Kenya
Male
Retrospective Studies

Chemicals

Anti-Retroviral Agents